Report cover image

Scar Treatment Market Report and Forecast 2025-2034

Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319783

Description

The scar treatment market size was valued at USD 22.56 Billion in 2024, driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets. The market is expected to grow at a CAGR of 11.00% during the forecast period of 2025-2034, to reach USD 64.06 Billion by 2034.

Scar Treatment Market Overview

Scar treatment includes a range of techniques and products used to reduce, mask, or completely remove scars on the skin. Scars may be caused by injuries, surgeries, burns, acne, and other skin disorders. It develops as a result of the body's natural healing process. Topical creams, gels, silicone sheets, laser therapy, surgery, and injections are amongst the common treatments for treating scars.

The scar treatment market growth is driven by individuals becoming more self-conscious about their appearance. This has resulted in increased scar removal and reduction treatments. Consequently, resulting in increased incidence in approvals from regulatory authorities. For instance, in August 2023, FDA approved Sofwave Medical Ltd.'s Precise SUPERB Applicator to treat acne scars, expanding its list of approved uses beyond cellulite. After three sessions, a multicenter clinical research spread across multiple US locations showed a notable improvement in the appearance of acne scars. Most patients expressed relief and great pleasure with their outcomes. There were no significant adverse events in the research, which showed a positive safety profile.

To meet the rising scar treatment market demand, mergers and collaborations are witnessing a significant surge. In June 2023, International Medical Lasers (IML) partnered with DEKA Trio to offer laser accessories, including a scanner for CO2 laser-assisted scar reconstruction. The terms of agreement also focused on an FDA approved novel scanner for surgical scar correction By collaborating with global medical providers and manufacturers, new-age and technology driven companies are bringing cutting-edge medical technology to the markets, further driving its growth.

The scar treatment market share for products and services continues to expand, driven by rising application in the realm of medical aesthetics for non-surgical alternatives. People are looking for less intrusive ways to repair scars and rejuvenate their skin instead of undergoing typical surgical procedures. As laser-based procedures for skin rejuvenation and scar correction become more common, there is an increasing demand for cutting-edge instruments and technology that can produce good outcomes with little risk or downtime.

Scar Treatment Market Trends

Scar Treatment Market Segmentation

Market Breakup by Scar Type
  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Contracture Scars
  • Stretch Marks
The market segmentation by treatment type includes atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. This market segment illustrates the different types of treatment types.

Market Breakup by Product
  • Topical Products
  
  • Creams

  •   
  • Gels

  •   
  • Silicon Sheets

  •   
  • Others
    • Laser Products
      
  • CO2 Laser

  •   
  • Pulse-dyed Laser

  •   
  • Others
    • Injectable
    • Others
    Based on products, the scar treatment market is segmented into topical products, laser products, injectables, and others. Topical products include creams, gels, silicone sheets, and other formulations. Laser products comprise CO2 lasers, pulse-dyed lasers, and other laser devices. Injectable treatments are also offered for scar management. These segments reflect the diverse range of scar treatment options available, catering to varying patient needs and preferences. From non-invasive topical solutions to advanced laser therapies and injectable treatments, the market offers a comprehensive array of products aimed at reducing the appearance of scars and improving skin texture, ensuring a tailored approach to scar management.

    Market Breakup by End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
    End-users of scar treatment include hospitals, and ambulatory surgical centers, among others. These healthcare facilities provide access to treatment to diverse patient populations and clinical needs.

    Market Breakup by Region
    • United States
    • EU-4 and the United Kingdom
      
  • Germany

  •   
  • France

  •   
  • Italy

  •   
  • Spain

  •   
  • United Kingdom
    • Japan
    • India
    Based on regions, the market is divided into United States, EU-4 (Germany, France, Italy, and Spain) and the United Kingdom, along with Japan, and India. These areas reflect diverse healthcare environments and consumer preferences across various geographic areas. United States with a robust healthcare infrastructure is expected to lead the market share in the forecast period, while India and Japan are likely to witness expedited market growth.

    Scar Treatment Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Alliance Pharma PLC
    • Perrigo Company plc
    • Newmedical Technology Inc.
    • Sonoma Pharmaceuticals, Inc.
    • HRA Pharma
    • Boston Scientific Corporation
    • CCA Industries, Inc.
    • Avita Medical,Inc.
    • Smith & Nephew PLC
    • Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
    • Sientra, Inc.
    • Mölnlycke Health Care AB
    • Merz Pharma
    • POLYTECH Health & Aesthetics GmbH
    • CYNOSURE LUTRONIC
    Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

    Key Highlights of the Report

    Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
    • Scar Type
    • Product
    • End User
    • Region
    • Atrophic Scars
    • Hypertrophic and Keloid Scars
    • Contracture Scars
    • Stretch Marks
    • Topical Products
    • Laser Products
    • Injectable
    • Others
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
    • United States
    • EU-4 and the United Kingdom
    • Japan
    • India
    • Market Drivers and Constraints
    • SWOT Analysis
    • Porter’s Five Forces Model
    • Key Demand Indicators
    • Key Price Indicators
    • Industry Events, Initiatives, and Trends
    • Value Chain Analysis
    • Market Structure
    • Company Profiles
      
  • Financial Analysis

  •   
  • Product Portfolio

  •   
  • Demographic Reach and Achievements

  •   
  • Mergers and Acquisitions

  •   
  • Certifications
    • Alliance Pharma PLC
    • Perrigo Company plc
    • Newmedical Technology Inc.
    • Sonoma Pharmaceuticals, Inc.
    • HRA Pharma
    • Boston Scientific Corporation
    • CCA Industries, Inc.
    • Avita Medical,Inc.
    • Smith & Nephew PLC
    • Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
    • Sientra, Inc.
    • Mölnlycke Health Care AB
    • Merz Pharma
    • POLYTECH Health & Aesthetics GmbH
    • CYNOSURE LUTRONIC
    Key Queries Solved in the Scar Treatment Market Report 
    • How is the market landscape expected to evolve in the forecast period?
    • What future trends can be anticipated in the market?
    • What will be the effect of each driver, challenge, and opportunity on the market?
    • Which regional market is expected to experience expedited growth during the forecast period?
    • Which production type will lead the market growth?
    • Which end user is expected to dominate the respective market segment?
    • What are the key research initiatives expected to boost the market value during the forecast period?
    • Which treatment type is poised to make the highest impact on the Scar treatment market growth?
    • What are the market shares, strategies, and product portfolios of the leading players in the market?
    • How is the regulatory landscape shaping the market?
    • What are the market dynamics, trends, and growth prospects in the key regional markets?
    • How is technology innovation impacting the development of scar treatment?
    • What are the investment opportunities and potential risks associated with the market?
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Scar Treatment Market Overview – 8 Major Markets
    3.1 Scar Treatment Market Historical Value (2018-2024)
    3.2 Scar Treatment Market Forecast Value (2025-2034)
    4 Scar Overview
    4.1 Guidelines and Stages
    4.2 Pathophysiology
    4.3 Screening and Diagnosis
    4.4 Scar Pathway
    5 Patient Profile
    5.1 Patient Profile Overview
    5.2 Patient Psychology and Emotional Impact Factors
    5.3 Risk Assessment and Scar Type Success Rate
    6 Scar Epidemiology Scenario and Forecast – 8 Major Markets
    6.1 8MM Epidemiology Scenario Overview (2018-2034)
    6.2 United States Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3 EU-4 and United Kingdom Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3.1 Germany Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3.2 France Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3.3 Italy Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3.4 Spain Scar Epidemiology Scenario and Forecast (2018-2034)
    6.3.5 United Kingdom Scar Epidemiology Scenario and Forecast (2018-2034)
    6.4 Japan Scar Epidemiology Scenario and Forecast (2018-2034)
    6.5 India Scar Epidemiology Scenario and Forecast (2018-2034)
    7 Scar Treatment Market Landscape – 8 Major Markets
    7.1 Scar Treatment: Developers Landscape
    7.1.1 Analysis by Year of Establishment
    7.1.2 Analysis by Company Size
    7.1.3 Analysis by Region
    7.2 Scar Treatment: Product Landscape
    7.2.1 Analysis by Scar Type
    7.2.2 Analysis by Product Type
    7.2.3 Analysis by End User
    8 Scar Challenges and Unmet Needs
    8.1 Scar Type Pathway Challenges
    8.2 Compliance and Drop-Out Analysis
    8.3 Awareness and Prevention Gaps
    9 Cost of Scar Treatment
    10 Scar Treatment Market Dynamics
    10.1 Market Drivers and Constraints
    10.2 SWOT Analysis
    10.3 Porter’s Five Forces Model
    10.4 Key Demand Indicators
    10.5 Key Price Indicators
    10.6 Industry Events, Initiatives, and Trends
    10.7 Value Chain Analysis
    11 Scar Treatment Market Segmentation (218-2034) - 8 Major Markets
    11.1 Scar Treatment Market (2018-2034) by Scar Type
    11.1.1 Market Overview
    11.1.2 Atrophic Scars
    11.1.3 Hypertrophic and Keloid Scars
    11.1.4 Contracture Scars
    11.1.5 Stretch Marks
    11.2 Scar Treatment Market (2018-2034) by Product
    11.2.1 Market Overview
    11.2.2 Topical Products
    11.2.2.1 Creams
    11.2.2.2 Gels
    11.2.2.3 Silicon Sheets
    11.2.2.4 Others
    11.2.3 Laser Products
    11.2.3.1 CO2 Laser
    11.2.3.2 Pulse-dyed Laser
    11.2.3.3 Others
    11.2.4 Injectable
    11.2.5 Others
    11.3 Scar Treatment Market (2018-2034) by End User
    11.3.1 Hospitals
    11.3.2 Ambulatory Surgical Centers
    11.3.3 Others
    11.4 Scar Treatment Market (2018-2034) by Region
    11.4.1 Market Overview
    11.4.2 United States
    11.4.3 EU-4 and the United Kingdom
    11.4.3.1 Germany
    11.4.3.2 France
    11.4.3.3 Italy
    11.4.3.4 Spain
    11.4.3.5 United Kingdom
    11.4.4 Japan
    11.4.5 India
    12 United States Scar Treatment Market (218-2034)
    12.1 United States Scar Treatment Market Historical Value (2018-2024)
    12.2 United States Scar Treatment Market Forecast Value (2025-2034)
    12.3 United States Scar Treatment Market (2018-2034) by Scar Type
    12.3.1 Market Overview
    12.3.2 Atrophic Scars
    12.3.3 Hypertrophic and Keloid Scars
    12.3.4 Contracture Scars
    12.3.5 Stretch Marks
    12.4 United States Scar Treatment Market (2018-2034) by Product
    12.4.1 Market Overview
    12.4.2 Topical Products
    12.4.2.1 Creams
    12.4.2.2 Gels
    12.4.2.3 Silicon Sheets
    12.4.2.4 Others
    12.4.3 Laser Products
    12.4.3.1 CO2 Laser
    12.4.3.2 Pulse-dyed Laser
    12.4.3.3 Others
    12.4.4 Injectable
    12.4.5 Others
    13 EU-4 and United Kingdom Scar Treatment Market (218-2034)
    13.1 EU-4 and United Kingdom Scar Treatment Market Historical Value (2018-2024)
    13.2 EU-4 and United Kingdom Scar Treatment Market Forecast Value (2025-2034)
    13.3 EU-4 and United Kingdom Scar Treatment Market (2018-2034) by Scar Type
    13.3.1 Market Overview
    13.3.2 Atrophic Scars
    13.3.3 Hypertrophic and Keloid Scars
    13.3.4 Contracture Scars
    13.3.5 Stretch Marks
    13.4 EU-4 and United Kingdom Scar Treatment Market (2018-2034) by Product
    13.4.1 Market Overview
    13.4.2 Topical Products
    13.4.2.1 Creams
    13.4.2.2 Gels
    13.4.2.3 Silicon Sheets
    13.4.2.4 Others
    13.4.3 Laser Products
    13.4.3.1 CO2 Laser
    13.4.3.2 Pulse-dyed Laser
    13.4.3.3 Others
    13.4.4 Injectable
    13.4.5 Others
    14 Japan Scar Treatment Market
    14.1 Japan Scar Treatment Market Historical Value (2018-2024)
    14.2 Japan Scar Treatment Market Forecast Value (2025-2034)
    14.3 Japan Scar Treatment Market (2018-2034) by Scar Type
    14.3.1 Market Overview
    14.3.2 Atrophic Scars
    14.3.3 Hypertrophic and Keloid Scars
    14.3.4 Contracture Scars
    14.3.5 Stretch Marks
    14.4 Japan Scar Treatment Market (2018-2034) by Product
    14.4.1 Market Overview
    14.4.2 Topical Products
    14.4.2.1 Creams
    14.4.2.2 Gels
    14.4.2.3 Silicon Sheets
    14.4.2.4 Others
    14.4.3 Laser Products
    14.4.3.1 CO2 Laser
    14.4.3.2 Pulse-dyed Laser
    14.4.3.3 Others
    14.4.4 Injectable
    14.4.5 Others
    15 India Scar Treatment Market
    15.1 India Scar Treatment Market (2018-2034) Historical Value (2018-2024)
    15.2 India Scar Treatment Market (2018-2034) Forecast Value (2025-2034)
    15.3 India Scar Treatment Market (2018-2034) by Scar Type
    15.3.1 Market Overview
    15.3.2 Atrophic Scars
    15.3.3 Hypertrophic and Keloid Scars
    15.3.4 Contracture Scars
    15.3.5 Stretch Marks
    15.4 India Scar Treatment Market (2018-2034) by Product
    15.4.1 Market Overview
    15.4.2 Topical Products
    15.4.2.1 Creams
    15.4.2.2 Gels
    15.4.2.3 Silicon Sheets
    15.4.2.4 Others
    15.4.3 Laser Products
    15.4.3.1 CO2 Laser
    15.4.3.2 Pulse-dyed Laser
    15.4.3.3 Others
    15.4.4 Injectable
    15.4.5 Others
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 Japan PMDA
    16.1.4 India CDSCO
    16.1.5 Others
    17 Patent Analysis
    17.1 Analysis by Drug Type of Patent
    17.2 Analysis by Publication Year
    17.3 Analysis by Issuing Authority
    17.4 Analysis by Patent Age
    17.5 Analysis by CPC Analysis
    17.6 Analysis by Patent Valuation
    17.7 Analysis by Key Players
    18 Grants Analysis
    18.1 Analysis by Year
    18.2 Analysis by Amount Awarded
    18.3 Analysis by Issuing Authority
    18.4 Analysis by Grant Application
    18.5 Analysis by Funding Institute
    18.6 Analysis by NIH Departments
    18.7 Analysis by Recipient Organization
    19 Clinical Trials Analysis
    19.1 Analysis by Trial Registration Year
    19.2 Analysis by Trial Status
    19.3 Analysis by Trial Phase
    19.4 Analysis by Therapeutic Area
    19.5 Analysis by Geography
    20 Funding and Investment Analysis
    20.1 Analysis by Funding Instances
    20.2 Analysis by Drug Type of Funding
    20.3 Analysis by Funding Amount
    20.4 Analysis by Leading Players
    20.5 Analysis by Leading Investors
    20.6 Analysis by Geography
    21 Partnership and Collaborations Analysis
    21.1 Analysis by Partnership Instances
    21.2 Analysis by Drug Type of Partnership
    21.3 Analysis by Leading Players
    21.4 Analysis by Geography
    22 Supplier Landscape
    22.1 Alliance Pharma PLC
    22.1.1 Financial Analysis
    22.1.2 Product Portfolio
    22.1.3 Demographic Reach and Achievements
    22.1.4 Mergers and Acquisitions
    22.1.5 Certifications
    22.2 Perrigo Company plc
    22.2.1 Financial Analysis
    22.2.2 Product Portfolio
    22.2.3 Demographic Reach and Achievements
    22.2.4 Mergers and Acquisitions
    22.2.5 Certifications
    22.3 Newmedical Technology Inc.
    22.3.1 Financial Analysis
    22.3.2 Product Portfolio
    22.3.3 Demographic Reach and Achievements
    22.3.4 Mergers and Acquisitions
    22.3.5 Certifications
    22.4 Sonoma Pharmaceuticals, Inc.
    22.4.1 Financial Analysis
    22.4.2 Product Portfolio
    22.4.3 Demographic Reach and Achievements
    22.4.4 Mergers and Acquisitions
    22.4.5 Certifications
    22.5 HRA Pharma
    22.5.1 Financial Analysis
    22.5.2 Product Portfolio
    22.5.3 Demographic Reach and Achievements
    22.5.4 Mergers and Acquisitions
    22.5.5 Certifications
    22.6 Boston Scientific Corporation
    22.6.1 Financial Analysis
    22.6.2 Product Portfolio
    22.6.3 Demographic Reach and Achievements
    22.6.4 Mergers and Acquisitions
    22.6.5 Certifications
    22.7 CCA Industries, Inc.
    22.7.1 Financial Analysis
    22.7.2 Product Portfolio
    22.7.3 Demographic Reach and Achievements
    22.7.4 Mergers and Acquisitions
    22.7.5 Certifications
    22.8 Avita Medical,Inc.
    22.8.1 Financial Analysis
    22.8.2 Product Portfolio
    22.8.3 Demographic Reach and Achievements
    22.8.4 Mergers and Acquisitions
    22.8.5 Certifications
    22.9 Smith & Nephew PLC
    22.9.1 Financial Analysis
    22.9.2 Product Portfolio
    22.9.3 Demographic Reach and Achievements
    22.9.4 Mergers and Acquisitions
    22.9.5 Certifications
    22.10 Shanghai Fosun Pharmaceutical?Group?Co., Ltd.
    22.10.1 Financial Analysis
    22.10.2 Product Portfolio
    22.10.3 Demographic Reach and Achievements
    22.10.4 Mergers and Acquisitions
    22.10.5 Certifications
    22.11 Sientra, Inc.
    22.11.1 Financial Analysis
    22.11.2 Product Portfolio
    22.11.3 Demographic Reach and Achievements
    22.11.4 Mergers and Acquisitions
    22.11.5 Certifications
    22.12 Mölnlycke Health Care AB
    22.12.1 Financial Analysis
    22.12.2 Product Portfolio
    22.12.3 Demographic Reach and Achievements
    22.12.4 Mergers and Acquisitions
    22.12.5 Certifications
    22.13 Merz Pharma
    22.13.1 Financial Analysis
    22.13.2 Product Portfolio
    22.13.3 Demographic Reach and Achievements
    22.13.4 Mergers and Acquisitions
    22.13.5 Certifications
    22.14 POLYTECH Health & Aesthetics GmbH
    22.14.1 Financial Analysis
    22.14.2 Product Portfolio
    22.14.3 Demographic Reach and Achievements
    22.14.4 Mergers and Acquisitions
    22.14.5 Certifications
    22.15 CYNOSURE LUTRONIC
    22.15.1 Financial Analysis
    22.15.2 Product Portfolio
    22.15.3 Demographic Reach and Achievements
    22.15.4 Mergers and Acquisitions
    22.15.5 Certifications
    23 Scar Treatment Market - Distribution Model (Additional Insight)
    23.1 Overview
    23.2 Potential Distributors
    23.3 Key Parameters for Distribution Partner Assessment
    24 Key Opinion Leaders (KOL) Insights (Additional Insight)
    25 Company Competitiveness Analysis (Additional Insight)
    25.1 Very Small Companies
    25.2 Small Companies
    25.3 Mid-Sized Companies
    25.4 Large Companies
    25.5 Very Large Companies
    26 Payment Methods (Additional Insight)
    26.1 Government Funded
    26.2 Private Insurance
    26.3 Out-of-Pocket
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.